Michail et al. [15] claimed that along with other three biomarkers (PTEN, SMAD4, and SPP1), nuclear CCND1 (HR = 1.99, P = 0.036) can be a valuable biomarker to predict lethal outcome of PCa. The gene discussed is PTEN; the disease is posterior cortical atrophy.